Press Releases

Year

28 Jan '19

AF Symposium 2019: Acutus AcQMap Imaging System Helps Physicians Eliminate Arrhythmia with a Single Ablation

22 Jan '19

AF Symposium 2019: Acutus Medical Announces Presentation of Late-Breaking Data Reinforcing Benefit of Non-Contact Cardiac Mapping

08 May '18

First Cardiac Procedure Using the AcQMap® System by Acutus Medical® Successfully Performed in the United States

New European/Canadian Clinical Study Initiated to Evaluate the AcQMap® System During an Atrial Fibrillation Retreatment Ablation Procedure Company to Present Data at the Heart Rhythm Society’s 39th Annual Scientific Sessions FDA clearance received on additional accessory sheath catheter CARLSBAD,

03 May '18

Stereotaxis and Acutus Medical Announce Strategic Collaboration

Formal testing supports joint use of the two systems Positive initial clinical experience demonstrates additive benefits of technologies Commitment to robust integration of technologies to enhance ease-of-use and lab efficiency St. Louis, MO and Carlsbad, CA - May 3, 2018 Stereotaxis (OTCQX:

24 Oct '17

Acutus Medical® Receives FDA Clearance for Advanced Cardiac Mapping Technology for Complex Arrhythmias

FDA clearance of the AcQMap® High Resolution Imaging and Mapping System and AcQMap® 3D Imaging and Mapping Catheter is a major milestone for Acutus Medical Clearance allows the AcQMap System to be used with commercially available cardiac ablation platforms CARLSBAD, CA — October 24, 2017 – Acutus

03 May '17

Acutus Medical® Receives FDA Clearance for AcQGuide™ Steerable Sheath

- Company will also present clinical data at the Heart Rhythm Society’s 38th Annual Scientific Sessions - CARLSBAD, CA — May 3, 2017 – Acutus Medical®, a company committed to transforming the lives of millions of patients with complex arrhythmias, today announced the FDA clearance of the AcQGuide

28 Apr '17

Acutus Medical® Announces Completion of Enrollment for UNCOVER AF™ Study of AcQMap® in Persistent Atrial Fibrillation

CARLSBAD, CA — April 27, 2017 – Acutus Medical®, a company committed to transforming the lives of millions of patients with complex arrhythmias, today announced that enrollment has been completed in its pivotal U tilizing N ovel Dipole Density C apabilities to O bjectively V isualize the E

23 Jan '17

FierceMedicalDevices names Acutus Medical® as one of its “Fierce 15” Medical Device Companies of 2016

CARLSBAD, CA — January 23, 2017 – Acutus Medical is a company committed to transforming the lives of millions of patients by providing electrophysiologists (EPs) a highly unique, dual platform portfolio of breakthrough products that image, diagnose and treat complex arrhythmias.

27 Oct '16

Acutus Medical® Announces First Patient Procedure in Pivotal Atrial Fibrillation Trial…

Acutus Medical® Announces First Patient Procedure in Pivotal Atrial Fibrillation Trial (UNCOVER-AF) and Introduction of the World’s First ElectroFunctional™ Procedure - European and Canadian Clinical Study Evaluates AcQMap® High Resolution Imaging and Mapping System - CARLSBAD, CA—October 26, 2016

18 May '16

Novel Ultrasound-based Imaging and Global Dipole Density Mapping: Feasibility in Persistent Atrial Fibrillation

Novel Ultrasound-based Imaging and Global Dipole Density Mapping: Feasibility in Persistent Atrial Fibrillation Heart Rhythm Society May 2016 Poster PO03 – 106 Julia Moser MD, Jana Nührich MD, Benjamin Schäffer MD, Ruken Özge Akbulak MD, Mario Jularic MD, Christian Eickholt MD, Pawel Kuklik PhD,

Pagination

First page
Previous page
…
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Current page 13
Page 14
Page 15
Next page
Last page

Displaying 121 - 130 of 145